Organon (OGN) EV to EBITDA (2021 - 2026)
Organon (OGN) posted EV to EBITDA of 7.5 for Q2 2026, up 285.64% on a QoQ basis from 1.95 in Q1 2026, and up 26.79% year-over-year from 5.92 in Q2 2025.
Analysis
Organon (OGN) EV to EBITDA (2021 - 2026) Analysis & Trends
Organon has reported EV to EBITDA for 6 years, with the latest figure at 7.5 in Q2 2026.
- On a quarterly basis, EV to EBITDA rose 26.79% year-over-year to 7.5 in Q2 2026; TTM through Jun 2026 was 2.15, a 39.31% increase from a year earlier, with the FY2025 full-year figure at 1.14, down 47.09% from the prior year.
- EV to EBITDA was 7.5 for Q2 2026 at Organon, up from 1.95 in the prior quarter.
- The five-year high for EV to EBITDA was 24.42 in Q4 2022, with the low at 1.95 in Q1 2026.
- Average EV to EBITDA over 5 years is 11.8, with a median of 12.16 recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: EV to EBITDA soared 44.02% in 2022, then tumbled 85.88% in 2026.
- Over 5 years, EV to EBITDA stood at 24.42 in 2022, then tumbled by 49.51% to 12.33 in 2023, then slipped by 11.52% to 10.91 in 2024, then sank by 43.59% to 6.15 in 2025, then climbed by 21.92% to 7.5 in 2026.
- The last three EV to EBITDA figures came in at 7.5 (Q2 2026), 1.95 (Q1 2026), and 6.15 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.50 |
| Mar 31, 2026 | 1.95 |
| Dec 31, 2025 | 6.15 |
| Sep 30, 2025 | 5.88 |
| Jun 30, 2025 | 5.92 |
| Mar 31, 2025 | 13.78 |
| Dec 31, 2024 | 10.91 |
| Sep 30, 2024 | 10.68 |
| Jun 30, 2024 | 11.98 |
| Mar 31, 2024 | 10.83 |
| Dec 31, 2023 | 12.33 |
| Sep 30, 2023 | 17.34 |
| Jun 30, 2023 | 12.83 |
| Mar 31, 2023 | 14.17 |
| Dec 31, 2022 | 24.42 |
| Sep 30, 2022 | 13.37 |
| Jun 30, 2022 | 17.18 |
| Mar 31, 2022 | 15.15 |
| Dec 31, 2021 | 16.96 |
| Sep 30, 2021 | 14.16 |